Industry: Pharmaceuticals, Biotechnology
Æterna Zentaris Inc. is a growing global biopharmaceutical company focused on oncology and endocrine therapy with proven expertise in drug discovery, development and commercialization. Æterna Zentaris also owns 48.3% of the equity of Atrium Biotechnologies Inc. (TSX: ATB) and 64.7% of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries. ( www.aeternazentaris.com )
Zentaris Inc
1405 Du Parc Technologique Blvd.
Québec, Québec G1P 4P5
Canada
Tel: (418) 652-8525
Fax: (418) 652-0881